76
Participants
Start Date
April 23, 2015
Primary Completion Date
June 14, 2019
Study Completion Date
June 14, 2019
Bevacizumab
Bevacizumab will be prescribed by the local clinician according to the SmPC and standard of care for up to 15 months. No treatment will be provided by the Sponsor in this non-interventional study.
Carboplatin
Carboplatin will be prescribed by the local clinician according to local labeling and standard of care for up to 18 weeks. No treatment will be provided by the Sponsor in this non-interventional study.
Paclitaxel
Paclitaxel will be prescribed by the local clinician according to local labeling and standard of care for up to 18 weeks. No treatment will be provided by the Sponsor in this non-interventional study.
CHU St Pierre (St Pierre), Brussels
Cliniques Uni Ires Saint-Luc; Gynaecology, Brussels
AZ Turnhout Sint Elisabeth, Turnhout
Sint Augustinus Wilrijk, Wilrijk
UZ Antwerpen, Edegem
Imeldaziekenhuis, Bonheiden
AZ KLINA, Brasschaat
UZ Leuven Gasthuisberg, Leuven
Jessa Zkh (Campus Virga Jesse), Hasselt
ZOL (Sint Jan), Genk
Chr de La Citadelle, Liège
CHU Sart-Tilman, Liège
Clinique Saint-Joseph, Liège
CHR de Verviers - East Belgium, Verviers
Clinique Ste-Elisabeth, Namur
GHdC Site Notre Dame, Charleroi
CH Jolimont - Lobbes (Jolimont), Haine-Saint-Paul
AZ Sint Jan, Bruges
AZ Sint Lucas Brugge, Assebroek
AZ Damiaan, Ostend
AZ Groeninge, Kortrijk
AZ Maria Middelares, Ghent
AZ Sint Lucas (Sint Lucas), Ghent
UZ Gent, Ghent
AZ Nikolaas (Sint Niklaas), Sint-Niklaas
Onze Lieve Vrouwziekenhuis Aalst, Aalst
Hoffmann-La Roche
INDUSTRY